KAUST and SABB (Saudi British Bank) have partnered to launch a startup accelerator program. The program will be open to multiple universities in Saudi Arabia. Details on the application process and specific program focus are forthcoming. Why it matters: University-linked accelerators boost Saudi Arabia's innovation ecosystem by providing resources for young companies.
28 student and faculty-led teams have been selected for the inaugural TAQADAM Accelerator Cohort at KAUST. The program is sponsored by the Saudi British Bank. Why it matters: This accelerator program will help foster entrepreneurship and innovation within the Saudi ecosystem.
KAUST and SABB announced the winners of the TAQADAM startup accelerator program, awarding over 4 million SAR in zero-equity funding to 11 startups. 10 winners were selected by judges to receive 375,000 SAR each, with an additional People's Choice award of the same amount. The 2020 cohort included startups from eCommerce, HealthTech, EdTech and FinTech. Why it matters: This program highlights the growing entrepreneurship ecosystem in Saudi Arabia, fostering innovation across diverse sectors and attracting international interest.
KAUST and the Saudi British Bank (SABB) are partnering in the TAQADAM Startup Accelerator program, supporting 82 entrepreneurs from 37 teams across 18 Saudi universities. The program offers up to SR75,000 ($20,000) in pre-seed funding from SABB, working spaces at KAUST, and mentorship over six months. The accelerator has awarded SR4.5 million ($1.2 million) in pre-seed funding to date and aims to contribute to economic development and job creation in line with Saudi Vision 2030. Why it matters: This collaboration fosters innovation and entrepreneurship in Saudi Arabia, providing crucial resources for startups in key technology sectors like AI and fintech.
KAUST and SABB have launched the fourth TAQADAM Startup Accelerator program, open to all entrepreneurs in Saudi Arabia. The six-month program offers accepted startups 150,000 SAR in zero-equity grant funding, mentorship, and access to co-working and lab facilities. Startups can compete for an additional 375,000 SAR in follow-on funding at the end of the program. Why it matters: This initiative is key to supporting the growth of the entrepreneurship ecosystem in Saudi Arabia and diversifying the Kingdom's economy, aligning with Saudi Vision 2030.
KAUST and SABB will award 10 million SAR to entrepreneurs in the fourth TAQADAM Startup Accelerator program, doubling the zero-equity grants from previous years to 150,000 SAR per startup. 59 startups across sectors like agriculture, logistics, and healthcare have joined the cohort. Participating startups will receive expert mentorship and training, industry exposure, and funding to invest in growth and development without sacrificing equity. Why it matters: This increased funding and support from KAUST and SABB signals a strong commitment to fostering a thriving deep-tech startup ecosystem in Saudi Arabia, providing crucial resources and mentorship to promising ventures.
The TAQADAM Startup Accelerator Program, in partnership with KAUST and the Saudi British Bank (SABB), awarded over 2 million SAR to startups at its finals. 28 startups pitched ideas to judges and investors, marking the program's third year of equipping entrepreneurs with skills to launch tech startups. Since 2016, TAQADAM has graduated 78 startups and awarded over 9 million SAR in funding. Why it matters: The initiative highlights Saudi Arabia's commitment to fostering entrepreneurship and diversifying its economy by supporting innovative ventures across various sectors.
The Research Products Development Company (RPDC) signed an agreement with The Saudi Vaccine and Biomanufacturing Center (SVBC) to establish a research and industrial center in Saudi Arabia for vaccine and biopharmaceutical development. Supported by KACST and hosted by KAUST, the SVBC will provide a state-of-the-art facility and a training platform. Cooperation agreements were also signed with GE for equipment supply and with Fujifilm Dayosent Biotechnology for MERS-CoV treatment development. Why it matters: This initiative aims to localize vaccine and advanced treatment industries in Saudi Arabia, create technical jobs, and reduce reliance on imports in line with Vision 2030.